An Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301

PHASE3CompletedINTERVENTIONAL
Enrollment

143

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

April 25, 2025

Study Completion Date

June 23, 2025

Conditions
Thyroid Eye Disease
Interventions
DRUG

Intervention/Treatment

VRDN-001 10 mg/kg (5 infusions of VRDN-001 10 mg/kg)

Trial Locations (45)

7070

Akdeniz University Medical Faculty Hospital, Antalya

14012

Hospital Arruzafa. Servicio de Oftalmologia, Córdoba

19104

Hospital of the University of Pennsylvania Perleman Center, Philadelphia

28034

Hospital Universitario Ramon y Cajal, Madrid

33136

University of Miami Miller School of Medicine, Bascom Palmer Eye Institute, Miami

34239

Sarasota Retina Institute, Sarasota

34295

Centre Hospitalier Universitaire de Montpellier Hopital Lapeyronie, Montpellier

34899

Marmara University Faculty of Medicine, Istanbul

37075

Universitatmedizin Gottingen, Göttingen

41009

Hospital Universitario Virgen de la Macarena, Seville

44800

Centre Hospitalier Universitaire De Nantes G.R. Laenne, Saint-Herblain

48152

Kahana Oculoplastic & Orbital Surgery, Livonia

49933

CHU Angers, Angers

50009

Hospital Universitario Miguel Servel, Zaragoza

60453

Vision Medical Research, Oak Lawn

77030

Baylor College of Medicine, Houston

77074

Neuro-Eye Clinical Trials, Houston

80809

Optimum Profesorskie Centrum Okulistyki, Gdansk

89144

Ophthalmic Plastic, Reconstructive, Orbital and Cosmetic Surgery, Las Vegas

90023

Advancing Research International, LLC, Los Angeles

Advancing Research International, LLC, Newport Beach

90033

USC Eye Institute, Los Angeles

92108

Cockerham Eye Consultants, PC, San Diego

94303

Stanford Byers Eye Institute, Palo Alto

02189

Ophthalmic Consultants of Boston, East Weymouth

07103

Rutgers New Jersey Medical School, Newark

08873

The Center for Eye and Facial Plastic Surgery, Somerset

05401

University of Vermont Medical Center, Burlington

98104-2430

University of Washington Medical Center, Seattle

Unknown

Charite - Universitatsmedizin Berlin KoR, Campus Virchow Klinikum, Klinik tor Augenheilkunde, Berlin

Universitatsklinikum Carl Gustav Carus, Dresden

Universitatsklinikum Essen AoR - Klinik fur Augenheilkunde, Essen

University Medical Center Freiburg, Freiburg im Breisgau

Amsterdam UMC, Amsterdam

Hospital Clinico San Carlos, Madrid

Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich

University Hospital Bristol and Weston NHS Foundation Trust- Bristol Eye Hospital, Bristol

Newcastle Eye Centre, Newcastle

15-276

Uniwersytecki Szpital Kliniczny w Bialymstoku, Bialystok

05-500

Centrum Medyczne Pulawska, Piaseczno

58-304

Centrum Medyczne Piasta, Wałbrzych

06230

Hacettepe Universitesi Tip Fakultesi, Ankara

06560

Gazi University Medical Faculty Hospital, Ankara

NW15QH

Imperial College Healthcare NHS Trust Western Eye Hospital, London

SE17EH

Guy's and St. Thomas Trust, London

All Listed Sponsors
lead

Viridian Therapeutics, Inc.

INDUSTRY